Previous Page  19 / 22 Next Page
Information
Show Menu
Previous Page 19 / 22 Next Page
Page Background

© 2016, BSM Consulting

17

Modern Glaucoma Surgery

ENDNOTES

1. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the

United States. Arch Ophthalmol 2004;122:532-8.

2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J

Ophthalmol 2006;90:262-7.

3. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open

angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol

1991;109:1090-5.

4. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized

trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-

angle glaucoma. Arch Ophthalmol 2002;120:701-13.

5. American Academy of Ophthalmology. Primary open-angle glaucoma: Preferred Practice Pattern. San

Francisco: American Academy of Ophthalmology; 2005.

6. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors

that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20; discussion

829-30.

7. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure

reduction in the treatment of normal-tension glaucoma Am J Ophthalmol 1998;126:498-505.

8. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression

between untreated patients with normal-tension glaucoma and patients with therapeutically reduced

intraocular pressures Am J Ophthalmol 1998;126:487-97.

9. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure

and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol

2002;120:1268-79.

10. Kass MA, Gordon MO, Gao F, et al. Delaying treatment of ocular hypertension: the ocular

hypertension treatment study. Arch Ophthalmol 2010;128:276-87.

11. Realini T. Selective laser trabeculoplasty: a review. J Glaucoma 2008;17:497-502.

12. Keltner JL, Johnson CA, Quigg JM, Cello KE, Kass MA, Gordon MO. Confirmation of visual field

abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group.

Arch Ophthalmol 2000;118:1187-94.

13. Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 1968;66:673-9.

14. Minckler D, Baerveldt G, Ramirez MA, et al. Clinical results with the Trabectome, a novel surgical

device for treatment of open-angle glaucoma. Trans Am Ophthalmol Soc 2006;104:40-50.

15. Minckler D, Mosaed S, Dustin L, Ms BF. Trabectome (trabeculectomy-internal approach): additional

experience and extended follow-up. Trans Am Ophthalmol Soc 2008;106:149-59; discussion 59-60.

16. Ahuja Y, Ma Khin Pyi S, Malihi M, Hodge DO, Sit AJ. Clinical Results of Ab Interno Trabeculotomy

Using the Trabectome for Open-Angle Glaucoma: The Mayo Clinic Series. Am J Ophthalmol 2013.

17. Francis BA, Singh K, Lin SC, et al. Novel glaucoma procedures: a report by the American Academy of

Ophthalmology. Ophthalmology 2011;118:1466-80.

18. Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE. Randomized evaluation of the

trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract.

Ophthalmology 2011;118:459-67.

19. Craven ER, Katz LJ, Wells JM, Giamporcaro JE. Cataract surgery with trabecular micro-bypass stent

implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J

Cataract Refract Surg 2012;38:1339-45.